Over the past 15 years we’ve learned that there are many hereditary cancer genes that, when mutated, increase the risk of cancer development. Not just BRCA1 and BRCA2 for hereditary breast and ovarian cancer. Not just the Lynch Syndrome genes and APC for hereditary...
In a recent video, we outlined the pros and cons of whole exome sequencing in children and newborns, currently a controversial topic in the field of genetics. After all, there is still a lot that scientists and healthcare providers don’t know...
The American College of Obstetricians and Gynecologists (ACOG) recently published a committee opinion for women of population risk to develop ovarian cancer. ACOG recommends that average risk women who are having gynecological surgery, such as removal of their uterus...
Last week in Genetic Privacy Part 1, we discussed the potential harm done when a patient chooses not to share her data with other family members. Such arguments, and the argument that widely sharing genetic data would advance scientific research, have made some...
